Edition:
United States

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

198.41USD
16 Oct 2017
Change (% chg)

$-7.11 (-3.46%)
Prev Close
$205.52
Open
$205.55
Day's High
$206.78
Day's Low
$192.22
Volume
1,459,175
Avg. Vol
493,464
52-wk High
$256.78
52-wk Low
$184.58

Stewart, Robert 

Mr. Robert A. Stewart is Chief Operating Officer of Allergan Plc., since May 2016. Prior to his current appointment, Mr. Stewart served as President, Generics and Global Operations from March 2015 to May 2016; Chief Operating Officer from July 2014 to March 2015; and President, Global Operations, from August 2010 to July 2014. He joined the Company (then Watson) in November 2009 as Senior Vice President, Global Operations. Prior to joining Watson, Mr. Stewart held various positions with Abbott Laboratories, Inc. from 2001 until 2009 where he most recently served as Divisional Vice President, Global Supply Chain, Quality Assurance and prior to this position served as Divisional Vice President for U.S./Puerto Rico and Latin America Plant Operations. Prior to joining Abbott Laboratories, Inc., he worked for Knoll Pharmaceutical Company from 1995 to 2001 and Hoffman La-Roche Inc. Mr. Stewart received B.S. degrees in Business Management / Finance from Fairleigh Dickinson University.

Basic Compensation

Total Annual Compensation, USD 1,468,200
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 27,635
Fiscal Year Total, USD 1,495,830

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 75,000 4,285,500.00